SUMMARY Calcium absorption, assessed by a double isotope method, was found to be impaired in postmenopausal women with rheumatoid arthritis of recent onset (mean 14-2 months) compared with controls. Circulating levels of 1,25-dihydroxyvitamin D (calcitriol) were higher than in controls, suggesting a primary malabsorption of calcium in these patients. The reduction in calcium absorption correlated with several measures of disease activity, suggesting that the disease process was responsible for the intestinal defect, but an effect from non-steroidal anti-inflammatory agents cannot be excluded. A primary reduction in calcium absorption may increase the risk of osteoporosis in women with rheumatoid arthritis. positive classical or definite RA7 in the preceding three years and who were approaching the menopause or were postmenopausal were asked to participate; patients receiving oral corticosteroids were excluded.
A generalised disturbance of skeletal metabolism has been suggested to occur in rheumatoid arthritis (RA) leading to osteoporosis. 1-3 Calcium homeostasis is regulated in part by changes in intestinal absorption of calcium, yet there have been few studies of calcium absorption in RA, and these have yielded conflicting results. Olhagen et al.4 found calcium absorption was reduced, whereas Kennedy et al.5 found it to be increased. Problems with methodology and the concomitant use of oral corticosteroids in some patients makes interpretation of both studies difficult.
In the present study we positive classical or definite RA7 in the preceding three years and who were approaching the menopause or were postmenopausal were asked to participate; patients receiving oral corticosteroids were excluded.
Control subjects were volunteers, in good health and not taking drugs known to produce osteoporosis; two were taking non-steroidal antiinflammatory drugs (NSAIDs) for minor degenerative joint disease. One control was subsequently excluded because she suffered from Parkinson's disease, and it was thought this might affect gut transit time. Details of patients and controls are shown in Table 1 The effective dose equivalent from the procedure was 0-76-0*95 mSv for the oral tracer and 0-10-0*16 mSv for the intravenous tracer. From the plasma activity-time curve for each tracer the spectrum of transit times from the gut lumen to plasma was derived by deconvolution. The fraction of dose absorbed (FA), maximum absorption rate (MAR), and mean absorption rate (AR) were calculated from the curve describing the spectrum of transit times. Blood samples were taken before the start of the calcium absorption study with the subjects fasting for determination of plasma calcium, albumin, and creatinine. Calcium values were corrected by adding or subtracting 0.02 mmoIIl for every 1 g/l the albumin was below or above 40 g/l. A fasting early morning urine specimen was collected on the day of the calcium absorption study for determination of calcium and creatinine.
25-Hydroxyvitamin D (calcidiol) levels were measured by a competitive protein binding assay. 10 The sensitivity of this method was 50 pg per tube with intra-assay and interassay variation of 10-1 and 13-2% respectively. The 1,25-dihydroxyvitamin D (calcitriol) levels were measured by a radioreceptor assay with an intestinal receptor preparation and by a modified extraction and separation procedure by high performance liquid chromatography.11 Intraassay and interassay variation were less than 10%, and the detection limit was less than 5 Cross-sectional bone density studies in our patients showed no significant differences in mean values when compared with controls. Since the RA in these patients was of recent onset, it is possible that significant changes in bone density might not have had time to develop. Longitudinal studies of bone density trends in these patients are currently in progress to determine whether the reductions in calcium absorption are related to the later development of osteoporosis.
In conclusion, calcium absorption appears to be reduced in RA due to a primary malabsorptive process; the mechanism is uncertain. Rates of calcium absorption correlated with several measures of disease activity, but an effect of NSAIDs cannot be excluded. Impaired calcium absorption will increase the risk of osteoporosis in RA.
